Is Organon Stock a Good Investment?
Organon Investment Advice | OGN |
- Examine Organon's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Organon's leadership team and their track record. Good management can help Organon navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Organon's business and its evolving consumer preferences.
- Compare Organon's performance and market position to its competitors. Analyze how Organon is positioned in terms of product offerings, innovation, and market share.
- Check if Organon pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Organon's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Organon Co stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Organon Co is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Organon Stock
Researching Organon's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 80.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 16th of August 2024.
To determine if Organon is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Organon's research are outlined below:
| Organon generated a negative expected return over the last 90 days | |
| Over 80.0% of the company shares are owned by institutional investors | |
| On 12th of September 2024 Organon paid $ 0.28 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Disposition of 42553 shares by Daniel Karp of Organon subject to Rule 16b-3 |
Organon Quarterly Cost Of Revenue |
|
Organon uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Organon Co. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Organon's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Organon's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Organon's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-02-16 | 2022-12-31 | 0.9 | 0.81 | -0.09 | 10 | ||
2022-02-17 | 2021-12-31 | 1.24 | 1.37 | 0.13 | 10 | ||
2023-11-02 | 2023-09-30 | 1.06 | 0.87 | -0.19 | 17 | ||
2022-11-03 | 2022-09-30 | 1.09 | 1.32 | 0.23 | 21 | ||
2021-11-11 | 2021-09-30 | 1.44 | 1.67 | 0.23 | 15 | ||
2024-05-03 | 2024-03-31 | 0.97 | 1.22 | 0.25 | 25 | ||
2023-08-08 | 2023-06-30 | 1.01 | 1.31 | 0.3 | 29 | ||
2021-08-12 | 2021-06-30 | 1.4 | 1.72 | 0.32 | 22 |
Know Organon's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Organon is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organon Co backward and forwards among themselves. Organon's institutional investor refers to the entity that pools money to purchase Organon's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Aqr Capital Management Llc | 2024-06-30 | 3.5 M | Deprince Race & Zollo Inc | 2024-06-30 | 3.4 M | Fmr Inc | 2024-06-30 | 2.8 M | Principal Financial Group Inc | 2024-06-30 | 2.7 M | Charles Schwab Investment Management Inc | 2024-06-30 | 2.4 M | Dimensional Fund Advisors, Inc. | 2024-06-30 | 2.4 M | Amvescap Plc. | 2024-06-30 | 2.2 M | Acadian Asset Management Llc | 2024-06-30 | 2.2 M | Thompson, Siegel & Walmsley Llc | 2024-06-30 | 2.1 M | Blackrock Inc | 2024-06-30 | 32.6 M | Vanguard Group Inc | 2024-06-30 | 30.2 M |
Organon's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 4.64 B.Market Cap |
|
Organon's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.15 | 0.14 | |
| Return On Capital Employed | 0.14 | 0.29 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | (14.61) | (13.88) |
Determining Organon's profitability involves analyzing its financial statements and using various financial metrics to determine if Organon is a good buy. For example, gross profit margin measures Organon's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Organon's profitability and make more informed investment decisions.
Organon's Earnings Breakdown by Geography
Evaluate Organon's management efficiency
Organon has Return on Asset of 0.0727 % which means that on every $100 spent on assets, it made $0.0727 of profit. This is way below average. Organon's management efficiency ratios could be used to measure how well Organon manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of October 2024, Return On Capital Employed is likely to grow to 0.29, while Return On Tangible Assets are likely to drop 0.14. At this time, Organon's Non Current Assets Total are very stable compared to the past year. As of the 11th of October 2024, Intangibles To Total Assets is likely to grow to 0.53, while Total Assets are likely to drop about 11.9 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.27) | (0.26) | |
| Tangible Book Value Per Share | (20.40) | (21.42) | |
| Enterprise Value Over EBITDA | 7.56 | 4.26 | |
| Price Book Value Ratio | (52.58) | (49.95) | |
| Enterprise Value Multiple | 7.56 | 4.26 | |
| Price Fair Value | (52.58) | (49.95) | |
| Enterprise Value | 14.5 B | 8.7 B |
The analysis of Organon's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Organon's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Organon Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0621 | Forward Dividend Yield 0.0621 | Forward Dividend Rate 1.12 | Beta 0.797 |
Basic technical analysis of Organon Stock
As of the 11th of October 2024, Organon holds the Coefficient Of Variation of (2,217), variance of 5.55, and Risk Adjusted Performance of (0.03). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organon, as well as the relationship between them.Organon's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Organon insiders, such as employees or executives, is commonly permitted as long as it does not rely on Organon's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Organon insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Organon's Outstanding Corporate Bonds
Organon issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Organon uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Organon bonds can be classified according to their maturity, which is the date when Organon Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US68621CAA71 Corp BondUS68621CAA71 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| US68622TAB70 Corp BondUS68622TAB70 | View |
Understand Organon's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Organon's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.75 | |||
| Coefficient Of Variation | (2,217) | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.55 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.10) | |||
| Maximum Drawdown | 12.47 | |||
| Value At Risk | (3.44) | |||
| Potential Upside | 3.01 | |||
| Skewness | (0.03) | |||
| Kurtosis | 1.52 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.75 | |||
| Coefficient Of Variation | (2,217) | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.55 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.10) | |||
| Maximum Drawdown | 12.47 | |||
| Value At Risk | (3.44) | |||
| Potential Upside | 3.01 | |||
| Skewness | (0.03) | |||
| Kurtosis | 1.52 |
Consider Organon's intraday indicators
Organon intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Organon stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Organon Corporate Filings
8K | 23rd of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 17th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 5th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Organon Stock media impact
Far too much social signal, news, headlines, and media speculation about Organon that are available to investors today. That information is available publicly through Organon media outlets and privately through word of mouth or via Organon internal channels. However, regardless of the origin, that massive amount of Organon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Organon news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Organon relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Organon's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Organon alpha.
Organon Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Organon can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Organon Historical Investor Sentiment
Investor biases related to Organon's public news can be used to forecast risks associated with an investment in Organon. The trend in average sentiment can be used to explain how an investor holding Organon can time the market purely based on public headlines and social activities around Organon Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Organon's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Organon and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Organon news discussions. The higher the estimate score, the more favorable the investor's outlook on Organon.
Organon Corporate Management
| Susan ONeal | Chief Officer | Profile | |
| Rebecca Edwards | Chief Officer | Profile | |
| Rachel Stahler | Executive Officer | Profile | |
| Susanne Fiedler | Executive Officer | Profile | |
| Daniel Karp | Chief Officer | Profile | |
| Aaron Falcione | Executive Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Dividend Share 1.12 | Earnings Share 3.88 | Revenue Per Share 24.784 | Quarterly Revenue Growth (0) |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Organon's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.